支气管内超声引导经支气管针吸活检用于非小细胞肺癌PD-L1检测
EBUS-TBNA组189例标本总体检测成功率为94.7%,与其他取材方法充分性无显著差异;高龄患者检测失败率较高。晚期N分期和脑转移与高PD-L1表达相关。
要点
- EBUS-TBNA标本用于NSCLC PD-L1检测的总体成功率为94.7%。
- EBUS-TBNA与其他取材方法的PD-L1检测充分性无显著差异。
- 晚期N分期和脑转移与高PD-L1表达相关。
核心结论
- EBUS-TBNA提供的标本足以用于NSCLC的PD-L1检测。
- 晚期N分期和存在脑转移与高PD-L1表达相关。
研究设计与样本
- 比较EBUS-TBNA与其他取材方法的PD-L1检测充分性并分析临床病理特征与PD-L1表达的关系。
主要发现
- EBUS-TBNA组189例标本中PD-L1检测总体成功率为94.7%。
- EBUS-TBNA与其他组织取材方法的检测充分性无显著差异。
- 高龄患者PD-L1检测失败率较高(OR 1.06;P = .008)。
- 多因素分析中晚期N分期(P = .048)和脑转移(P < .001)与高PD-L1表达相关。
临床怎么用
- 临床可考虑采用EBUS-TBNA标本进行NSCLC的PD-L1检测。
- 对高龄患者需关注PD-L1检测失败风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Programmed death-ligand 1 (PD-L1) expression on cancer cells is a clinically important biomarker to select patients with non-small cell lung cancer (NSCLC) for treatment with programmed death-1/PD-L1 inhibitors. Clinical trials of immunotherapy in patients with NSCLC have required histologic evidence for PD-L1 testing; in clinical practice, cytologic samples commonly are acquired in patients with advanced disease. RESEARCH QUESTION: This study aims to investigate whether endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) samples are adequate for PD-L1 testing in NSCLC. STUDY DESIGN AND METHODS: This study investigates the sampling adequacy of EBUS-TBNA for PD-L1 testing when compared with other methods. Furthermore, the relationship between clinicopathologic characteristics and PD-L1 expression in the study population have been examined. Five hundred seventy-seven NSCLC specimens were analyzed from consecutive patients with NSCLC across six centers in the United Kingdom and one center in the United States between January 2015 and December 2016. RESULTS: In the EBUS-TBNA group (189 specimens), the overall percentage of patients with successful PD-L1 testing was 94.7%. There was no significant difference in sampling adequacy with other methods of tissue acquisition. Older patients had higher failure rates of PD-L1 testing (OR, 1.06; P = .008). In multivariate analysis, advanced N-stage (P = .048) and presence of brain metastasis (P < .001) were associated with high PD-L1 expression. INTERPRETATION: This large multicenter study shows that EBUS-TBNA provides samples adequate for PD-L1 testing and that advanced N stage and the presence of brain metastasis are associated with high PD-L1 expression.
引用
- Perrotta F, Nankivell M, Adizie JB, et al. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer. Chest. 2020. PMID: 32428509. doi:10.1016/j.chest.2020.04.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。